Statistics

Total Visits

Views
BEndamustine plus rituximab in first line systemic treatment for extranodal malt lymphoma: Final results of phase ii trial of the spanish lymphoma study group (geltamo)62

Select a period of time:

Number of views in the range

Views
BEndamustine plus rituximab in first line systemic treatment for extranodal malt lymphoma: Final results of phase ii trial of the spanish lymphoma study group (geltamo)28

Views

Views
April 20252
May 20251
June 202510
July 202514
August 20250
September 20251
October 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Hong Kong10
Brazil8
United States5
United Kingdom2
Argentina1
Colombia1
Spain1
 

Top cities views

Views
Hong Kong10
Barnstaple1
Brasília1
Chicago1
Council Bluffs1
Feira de Santana1
Ocala1
Philadelphia1
Piracicaba1
Poços de Caldas1